The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Imipenem-Global Market Insights and Sales Trends 2025
Synopsis
Imipenem is a broad spectrum carbapenem antibiotic which is used for severe bacterial infections.
The global Imipenem market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Imipenem in various end use industries. The expanding demands from the Injection and Other, are propelling Imipenem market. Sterile Type, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-sterile Type segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Imipenem market, driven by demand from China, the second largest economy with some signs of stabilising, the Imipenem market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Imipenem, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Imipenem market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Imipenem market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Imipenem sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Imipenem covered in this report include Savior Lifetec, Sun Pharmaceutical Industries, HISUN Pharmaceutical, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical and HISOAR, etc.
The global Imipenem market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Savior Lifetec
Sun Pharmaceutical Industries
HISUN Pharmaceutical
Haibin Pharmaceutical
Jiangxi Fushine Pharmaceutical
HISOAR
Global Imipenem market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Imipenem market, Segment by Type:
Sterile Type
Non-sterile Type
Global Imipenem market, by Application
Injection
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Imipenem manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Imipenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Imipenem is a broad spectrum carbapenem antibiotic which is used for severe bacterial infections.
The global Imipenem market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Imipenem in various end use industries. The expanding demands from the Injection and Other, are propelling Imipenem market. Sterile Type, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-sterile Type segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Imipenem market, driven by demand from China, the second largest economy with some signs of stabilising, the Imipenem market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Imipenem, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Imipenem market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Imipenem market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Imipenem sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Imipenem covered in this report include Savior Lifetec, Sun Pharmaceutical Industries, HISUN Pharmaceutical, Haibin Pharmaceutical, Jiangxi Fushine Pharmaceutical and HISOAR, etc.
The global Imipenem market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Savior Lifetec
Sun Pharmaceutical Industries
HISUN Pharmaceutical
Haibin Pharmaceutical
Jiangxi Fushine Pharmaceutical
HISOAR
Global Imipenem market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Imipenem market, Segment by Type:
Sterile Type
Non-sterile Type
Global Imipenem market, by Application
Injection
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Imipenem manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Imipenem in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Imipenem Market Overview
1.1 Imipenem Product Overview
1.2 Imipenem Market Segment by Type
1.2.1 Sterile Type
1.2.2 Non-sterile Type
1.3 Global Imipenem Market Size by Type
1.3.1 Global Imipenem Market Size Overview by Type (2018-2029)
1.3.2 Global Imipenem Historic Market Size Review by Type (2018-2023)
1.3.3 Global Imipenem Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Imipenem Sales Breakdown by Type (2018-2023)
1.4.2 Europe Imipenem Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Imipenem Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Imipenem Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Imipenem Sales Breakdown by Type (2018-2023)
2 Global Imipenem Market Competition by Company
2.1 Global Top Players by Imipenem Sales (2018-2023)
2.2 Global Top Players by Imipenem Revenue (2018-2023)
2.3 Global Top Players by Imipenem Price (2018-2023)
2.4 Global Top Manufacturers Imipenem Manufacturing Base Distribution, Sales Area, Product Type
2.5 Imipenem Market Competitive Situation and Trends
2.5.1 Imipenem Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Imipenem Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imipenem as of 2022)
2.7 Date of Key Manufacturers Enter into Imipenem Market
2.8 Key Manufacturers Imipenem Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Imipenem Status and Outlook by Region
3.1 Global Imipenem Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Imipenem Historic Market Size by Region
3.2.1 Global Imipenem Sales in Volume by Region (2018-2023)
3.2.2 Global Imipenem Sales in Value by Region (2018-2023)
3.2.3 Global Imipenem Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Imipenem Forecasted Market Size by Region
3.3.1 Global Imipenem Sales in Volume by Region (2024-2029)
3.3.2 Global Imipenem Sales in Value by Region (2024-2029)
3.3.3 Global Imipenem Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Imipenem by Application
4.1 Imipenem Market Segment by Application
4.1.1 Injection
4.1.2 Other
4.2 Global Imipenem Market Size by Application
4.2.1 Global Imipenem Market Size Overview by Application (2018-2029)
4.2.2 Global Imipenem Historic Market Size Review by Application (2018-2023)
4.2.3 Global Imipenem Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Imipenem Sales Breakdown by Application (2018-2023)
4.3.2 Europe Imipenem Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Imipenem Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Imipenem Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Imipenem Sales Breakdown by Application (2018-2023)
5 North America Imipenem by Country
5.1 North America Imipenem Historic Market Size by Country
5.1.1 North America Imipenem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Imipenem Sales in Volume by Country (2018-2023)
5.1.3 North America Imipenem Sales in Value by Country (2018-2023)
5.2 North America Imipenem Forecasted Market Size by Country
5.2.1 North America Imipenem Sales in Volume by Country (2024-2029)
5.2.2 North America Imipenem Sales in Value by Country (2024-2029)
6 Europe Imipenem by Country
6.1 Europe Imipenem Historic Market Size by Country
6.1.1 Europe Imipenem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Imipenem Sales in Volume by Country (2018-2023)
6.1.3 Europe Imipenem Sales in Value by Country (2018-2023)
6.2 Europe Imipenem Forecasted Market Size by Country
6.2.1 Europe Imipenem Sales in Volume by Country (2024-2029)
6.2.2 Europe Imipenem Sales in Value by Country (2024-2029)
7 Asia-Pacific Imipenem by Region
7.1 Asia-Pacific Imipenem Historic Market Size by Region
7.1.1 Asia-Pacific Imipenem Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Imipenem Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Imipenem Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Imipenem Forecasted Market Size by Region
7.2.1 Asia-Pacific Imipenem Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Imipenem Sales in Value by Region (2024-2029)
8 Latin America Imipenem by Country
8.1 Latin America Imipenem Historic Market Size by Country
8.1.1 Latin America Imipenem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Imipenem Sales in Volume by Country (2018-2023)
8.1.3 Latin America Imipenem Sales in Value by Country (2018-2023)
8.2 Latin America Imipenem Forecasted Market Size by Country
8.2.1 Latin America Imipenem Sales in Volume by Country (2024-2029)
8.2.2 Latin America Imipenem Sales in Value by Country (2024-2029)
9 Middle East and Africa Imipenem by Country
9.1 Middle East and Africa Imipenem Historic Market Size by Country
9.1.1 Middle East and Africa Imipenem Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Imipenem Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Imipenem Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Imipenem Forecasted Market Size by Country
9.2.1 Middle East and Africa Imipenem Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Imipenem Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Savior Lifetec
10.1.1 Savior Lifetec Company Information
10.1.2 Savior Lifetec Introduction and Business Overview
10.1.3 Savior Lifetec Imipenem Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Savior Lifetec Imipenem Products Offered
10.1.5 Savior Lifetec Recent Development
10.2 Sun Pharmaceutical Industries
10.2.1 Sun Pharmaceutical Industries Company Information
10.2.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.2.3 Sun Pharmaceutical Industries Imipenem Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sun Pharmaceutical Industries Imipenem Products Offered
10.2.5 Sun Pharmaceutical Industries Recent Development
10.3 HISUN Pharmaceutical
10.3.1 HISUN Pharmaceutical Company Information
10.3.2 HISUN Pharmaceutical Introduction and Business Overview
10.3.3 HISUN Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2018-2023)
10.3.4 HISUN Pharmaceutical Imipenem Products Offered
10.3.5 HISUN Pharmaceutical Recent Development
10.4 Haibin Pharmaceutical
10.4.1 Haibin Pharmaceutical Company Information
10.4.2 Haibin Pharmaceutical Introduction and Business Overview
10.4.3 Haibin Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Haibin Pharmaceutical Imipenem Products Offered
10.4.5 Haibin Pharmaceutical Recent Development
10.5 Jiangxi Fushine Pharmaceutical
10.5.1 Jiangxi Fushine Pharmaceutical Company Information
10.5.2 Jiangxi Fushine Pharmaceutical Introduction and Business Overview
10.5.3 Jiangxi Fushine Pharmaceutical Imipenem Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jiangxi Fushine Pharmaceutical Imipenem Products Offered
10.5.5 Jiangxi Fushine Pharmaceutical Recent Development
10.6 HISOAR
10.6.1 HISOAR Company Information
10.6.2 HISOAR Introduction and Business Overview
10.6.3 HISOAR Imipenem Sales, Revenue and Gross Margin (2018-2023)
10.6.4 HISOAR Imipenem Products Offered
10.6.5 HISOAR Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Imipenem Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Imipenem Industrial Chain Analysis
11.4 Imipenem Market Dynamics
11.4.1 Imipenem Industry Trends
11.4.2 Imipenem Market Drivers
11.4.3 Imipenem Market Challenges
11.4.4 Imipenem Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Imipenem Distributors
12.3 Imipenem Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
